FDA Guidance on Cannabis Research: A Glimpse of What’s To Come for CBD Products?

Canna Law Blog
By Nathalie BougeniesJul 24, 2020, 10:00 am280 pts
On Tuesday, July 21, the Food and Drug Administration (“FDA”) released draft guidance for clinical research related to the development and manufacturing of cannabis-based drugs, which gained particular interest following the legalization of hemp in December 2018. Although the guidance does not cover other…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

DNA Genetics’ Top 5 Cannabis Seeds in 2025 77

DOJ Budget Advances with Restrictions on Rescheduling, Medical Cannabis Businesses 77

Ole Miss loses federal contract to grow research-grade marijuana 75

Analysis: Adult-Use Cannabis States Experience Significantly Higher Home Value Growth 73

New Texas Bill Would Protect Consumers Who Try To Buy Legal Hemp Products But Get Marijuana Instead 73

NJCRC Announces 1st Legal Consumption Area Endorsement Winners 73

New legislation in Germany could impact Canadian cannabis exports 73

House Spending Bill Provision Seeks to Block Cannabis Rescheduling Process 72

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.